FindTrial
Sign In

Comparison of intrathecal low-dose ropivacaine, bupivacaine and lidocaine for knee arthroscopy in ambulatory setting. a randomised, double-blind trial;

Comparison of intrathecal low-dose ropivacaine, bupivacaine and lidocaine for knee arthroscopy in ambulatory setting. a randomised, double-blind trial;

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-006125-28-BE
Enrollment
Unknown
Registered
2007-11-12
Start date
2007-12-17
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male and female patients, scheduled for an elective knee arthroscopy.

Interventions

Trade Name: Naropin Pharmaceutical Form: Injection* INN or Proposed INN: ROPIVACAINE HYDROCHLORIDE Concentration unit: % percent Concentration type: equal Concentration number: 0.5- Trade Name: Marca

Sponsors

University Hospitals Leuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: male and female patients, 18 years old or older scheduled to undergo an elective knee arthroscopy ASA I and II Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: patients who take anti-depressants or/and anti-psychotics allergies to local anaesthetics ASA III and IV

Design outcomes

Primary

MeasureTime frame
Main Objective: Which local anaesthetic will be superior with respect to: preoperative anaesthesia immediate postoperative analgesia recovery of sensory and motor block shortest voiding and discharge time;Secondary Objective: ;Primary end point(s):—

Countries

Belgium

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026